Disease And Therapy Review: Rheumatoid Arthritis

New report "Disease and Therapy Review: Rheumatoid Arthritis " available through Aarkstore Enterprise

By: Pushpanjali
The Rheumatoid Arthritis Disease and Therapy Review provides an overview of the disease and related conditions, with incidence and prevalence numbers and percentages for major countries worldwide, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the rheumatoid arthritis market, as well as sales of leading drugs and therapies are provided.

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format.  These reports are prepared by the senior market research team of Timely Data Resources.  Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities.  Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends.  The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment.  This information is supplemented by reviews of analyst reports, company reports, and medical websites.  Sources and references are provided.  

Table of Contents :  

I. Overview

II. Incidence and Prevalence

Incidence Table: (US, UK, France, Worldwide)

Prevalence Table: (US, UK, France, Germany, Italy, Spain, Japan, China, India, Mexico, Worldwide)

III. TREATMENT and Dosing

NSAIDs

Corticosteroids

Disease-modifying antirheumatic drugs (synthetic DMARDs)

Methotrexate (MTX)

Sulfasalazine

Leflunomide

Minocycline

Biologic DMARDs: Tumor necrosis factor (TNF) inhibitors

IV. DOSING

V. MARKET SIZE

VI. COMMENTS

VII. References/Resources

For more information please contact :

http://www.aarkstore.com/reports/Disease-and-Therapy-Review-Rheumatoid-Arthritis-6633.html

http://blogs.aarkstore.com/

From: Aarkstore Enterprise

Contact: Neel

Email: press@aarkstore.com

URL: www.aarkstore.com

Pushpanjali
Marketing Manager
contact@aarkstore.com
http://www.aarkstore.com
http://blogs.aarkstore.com









Related Articles

Disease Rheumatoid ArthritisDo you have Graves disease? If so, then you must be suffering from rheumatoid arthritis as well. Graves disease and rheumatoid arthritis are two disea...
Physical Therapy For Rheumatoid ArthritisRheumatoid arthritis is an autoimmune disease that affects many tissues and organs like the joints commonly known as synovial. Autoimmune diseases can...
Rheumatoid_ArthritisWhile there is no cure, there are several drugs and types of therapy for Rheumatoid Arthritis. Unfortunately, many of the drugs used to treat this aut...
Nutrition rheumatoid arthritisRheumatoid Arthritis is a name derived from Rheumatic Fever. This disease resembles from Rheumatic Fever that's why named as 'Rheumatoid'. It is a chr...
rheumatoid arthritis kneeRheumatoid arthritis is a disease that attacks the joints in the body, causing inflammation and pain. It can affect anyone at any age. Children are no...